Lsd1 ChIP-seq analysis. by Petri Rummukainen (4247122)

SMCR8 regulates mTOR signaling and autophagy. by Janet Ugolino (3359054)

“…<p><b>A)</b> Immunoblot analysis of mTOR activity after starvation and amino acid stimulation. …”

Plasma metabolites that significantly differ between HFD-fed and chow-fed minipigs. by Ditte Olsen Lützhøft (10837857)

Biochemical parameters of European seabass treated with natural zeolite as removal of stressful ammonia concentrations. by Ghada R. Sallam (18319994)

CgA silencing, processing enzyme inhibition and functional analysis of CgA peptides in SI-NEN cell lines. by Francesco Giovinazzo (487256)

“…Inhibition of the CgA processing enzyme prohormone convertase using Decanoyl-Arg-Val-Lys-Arg-CMK also decreased proliferation of H-STS cells (25 µM [<i>data not shown</i>] and 50 µM, <b>4D</b>, *<i>p</i><0.05). …”

<i>A</i>ltered gene expression profiles in the median and pectoral fin of <i>Tg(Inta11:NTR)</i> larvae following metronidazole treatment. by Robert L. Lalonde (4840260)

“…Inta11: NTR + MTZ show a decrease in distal <i>hoxa13a</i> expression (red arrow) in the median fin at 60hpf (B), and in the pectoral fin at 72hpf (D) compared to Inta11: NTR—MTZ (green arrow) (A, C). …”

The optimization of manipulation order between ICSI and SCC transfer. by Xiaoyu Liao (8161995)

B6 <i>mA3</i> is a saturable innate restriction factor <i>in vivo</i>. by Diana S. Smith (176104)

Do children and adolescents who consume ultra-processed foods have a worse lipid profile? A systematic review by Jéssica Batista Beserra (5222036)

Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio by Julian Laux (13047767)

“…., tofacitinib, 0.2–0.4 μmol/kg bid) in clinical use, suggesting an efficient underlying mode of action. We hypothesized that their effectiveness is due to their ability to raise the ratio of IL-10 to TNFα. …”

Actions to Include in a Farm Environment Plan by Annabel McAleer (15329209)

“…This interactive infographic is a compilation of actions to decrease the loss of contaminants from agricultural land. …”

Supplementary materials. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament by Emilie Moore Rosset (3801652)

Summary of subgroup analysis results. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Included and excluded studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Characteristics of included studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Extraction data table. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…The IC₅₀ value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…The IC₅₀ value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”